AgomAb Therapeutics NV director Patel Naimish received 56,328 derivative securities on 2026-09-11, leaving him with the same number afterward. The award represents about 100.0% of his resulting derivative-securities holding, giving investors a precise record of the director’s post-transaction position and the nature of the insider activity.

Key Highlights

  • The filing records Patel Naimish’s award under transaction code A.
  • The transaction occurred on 11 September 2026.
  • The award represents about 100.0% of Naimish’s resulting derivative-securities holding.

AgomAb Therapeutics NV director Patel Naimish was awarded 56,328 derivative securities on 11 September 2026, and his resulting holding was listed at 56,328 derivative securities. The award represents about 100.0% of his resulting derivative-securities position. Naimish is identified as a director of AgomAb Therapeutics NV.

Award Classified as Insider Grant

The filing records the transaction under code A and states that Naimish was awarded derivative securities. The recorded security class is derivative securities of AgomAb Therapeutics NV.